The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

  • This share is currently suspended. It was suspended at a price of 5.375

Share Price Information for Iconic Labs (ICON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.375
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.375
ICON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Consulting & Marketing Joint Venture

14 Jan 2020 09:00

RNS Number : 6597Z
Iconic Labs PLC
14 January 2020
 

14 January 2020

Iconic Labs Plc ("Iconic Labs" or the "Company")

New Consulting & Marketing Joint Venture

 

Iconic Labs Plc (LSE:ICON), a multi-divisional new media and technology business, is pleased to announce that it has created a 50/50 joint venture marketing services company with Bacchus Creative Entertainment ("Bacchus") called Coalition Media Limited ("Coalition").

 

Coalition has been established to utilise the industry leading expertise of the Iconic Labs team in understanding social media, digital content production and access to media platforms like GSN to assist clients of Bacchus. The Iconic Labs team will also utilise the expertise and contacts of the Bacchus team in creating music, managing events and procuring celebrity talent for potential clients of Iconic Labs.

 

Bacchus Creative Entertainment has expertise in music creation and supervision, strategic partnerships, celebrity procurement and event management. It has previously worked with clients including Jack Daniel's, Lotus F1 and Dior, and has worked with celebrities such as Kate Moss, Daft Punk and Emily Ratajkowski.

 

Under the terms of the agreement, Coalition's new board will include John Quinlan, Sam Asante and Liam Harrington from Iconic Labs and Damon Bryant and Edward Hoyland from Bacchus. The Joint Venture requires no financial investment from either party. Bacchus was previously introduced to Iconic Labs by David Sefton who helped facilitate the creation of the joint venture.

 

Iconic Chief Business Officer, Liam Harrington, said, "We are delighted to announce the creation of this Joint Venture. We believe this is the start of a complementary and strategically beneficial partnership that fully utilises our expertise in digital media and access to media platforms in addition to Bacchus's expertise in music and events as well as strong client base. We are confident that combining the expertise of both teams' will result in an exciting business and a strong pipeline of clients."

 

Bacchus partner, Damon Bryant, said, "We are delighted to be partnering with the team at Iconic Labs. As a creative agency with very diverse clients this partnership adds a new and very exciting dimension to what we can offer."

 

**ENDS**

 

For further information, please visit the Company's website www.iconiclabs.co.uk or contact:

 

John Quinlan

Iconic Labs Plc

c/o SBP Tel: +44 (0) 20 7236 1177

Damon Heath

Shard Capital Partners LLP

Tel: +44 (0) 20 7186 9950

Simon Leathers

Shard Capital Partners LLP

Tel: +44 (0) 20 7186 9007

Isabel de Salis

St Brides Partners Limited

Tel: +44 (0) 20 7236 1177

David Penson

St Brides Partners Limited

Tel: +44 (0) 20 7236 1177

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
JVEDXLFFBFLLBBF
Date   Source Headline
28th Mar 20247:00 amRNSInterim Results
11th Mar 202412:00 pmRNSHeads of Terms Signed
29th Feb 20247:00 amRNSTotal Voting Rights
29th Feb 20247:00 amRNSSuspension of Trading
13th Feb 20242:08 pmRNSResult of AGM
7th Feb 20249:10 amRNSConversion of Notes and Allotment of Shares
19th Jan 20243:49 pmRNSNotice of AGM
4th Jan 20247:00 amRNSBoard Changes & Business and Strategy Update
29th Dec 20237:00 amRNSTotal Voting Rights
7th Dec 20238:53 amRNSConversion of Securities
4th Dec 20237:53 amRNSConversion of Securities
30th Nov 20237:00 amRNSTotal Voting Rights
17th Nov 202311:32 amRNSConversion of Securities
13th Nov 20238:40 amRNSConversion of Securities
2nd Nov 202310:35 amRNSConversion of Securities
31st Oct 20239:29 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSFull Year Results for the Year ended 30 June 2023
24th Oct 20235:31 pmRNSChange of Auditor
17th Oct 20237:51 amRNSConversion of Securities
13th Oct 202311:32 amRNSAnnouncement of the Completion of CVA
13th Oct 202311:30 amRNSConversion of Securities
29th Sep 20238:01 amRNSTotal Voting Rights
22nd Sep 20239:40 amRNSConversion of Securities
18th Sep 20236:27 pmRNSConversion of Notes – Replacement
18th Sep 20237:37 amRNSConversion of Securities
12th Sep 20238:45 amRNSStatement re CVA
4th Sep 202312:02 pmRNSConversion of Securities
31st Aug 20237:21 amRNSTotal Voting Rights
25th Aug 20234:49 pmRNSResult of AGM
18th Aug 20237:51 amRNSConversion of Securities
14th Aug 20237:59 amRNSIssue of Debt
8th Aug 20232:58 pmRNSPublication of a Prospectus
4th Aug 20234:19 pmRNSNotice of AGM
30th Jun 20239:12 amRNSTotal Voting Rights
2nd Jun 20231:20 pmRNSIssue of Equity
28th Apr 202310:35 amRNSTotal Voting Rights
12th Apr 20238:13 amRNSConversion of Securities
31st Mar 20233:11 pmRNSTotal Voting Rights
31st Mar 20231:59 pmRNSHalf-year Report
29th Mar 20232:05 pmRNSSecond Price Monitoring Extn
29th Mar 20232:00 pmRNSPrice Monitoring Extension
28th Mar 20237:42 amRNSConversion of Securities
27th Mar 202311:05 amRNSSecond Price Monitoring Extn
27th Mar 202311:00 amRNSPrice Monitoring Extension
22nd Mar 202311:48 amRNSSubscription of Convertible Notes
21st Mar 202311:05 amRNSSecond Price Monitoring Extn
21st Mar 202311:00 amRNSPrice Monitoring Extension
21st Mar 20239:05 amRNSSecond Price Monitoring Extn
21st Mar 20239:00 amRNSPrice Monitoring Extension
20th Mar 20234:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.